-
FDA approves new allergy drug for children
MONMOUTH JUNCTION, N.J. — The Food and Drug Administration has approved a new drug for allergies in children made by Tris Pharma, the drug maker said Wednesday.
Tris announced the approval of Karbinal ER (carbinoxamine maleate) extended-release oral suspension in the 4 mg-per-five milliliter strength. The company said the drug was the first sustained-release histamine receptor blocking agent for seasonal and perennial allergic rhinitis in children 2 and older.
-
Kimberly Clark enlists celebrity endorsers for Depend's 'The Great American Try On' to support cancer research
DALLAS — Depend on Wednesday "boldly" re-invited Americans to join The Great American Try On and announced new and expanded celebrity partnerships designed to help give the millions of people living with bladder control issues the confidence to enjoy an active lifestyle.